arrow
A

Arnaud Petit

Assistance Publique-Hopitaux de Marseille
H指数:41
被引数:5,997

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sinusoidal obstruction syndrome in children with B‐acute lymphoblastic leukemia (B‐ALL) treated with inotuzumab ozogamicin: Results from the ITCC‐059 trial

窦性阻塞综合征在用伊诺妥单抗奥佐米星治疗B-急性淋巴细胞白血病(B-ALL)的儿童中的发生情况:ITCC-059试验结果

2026-08-210
OAAI
Genomic landscape of acute myeloid leukemia in adolescents and young adults

青少年和年轻成人急性髓系白血病的基因组景观

Leukemia
IF13.4
2026-06-250
PRE
Population pharmacokinetics and dose-response relationships of mitoxantrone in children with acute myeloid leukaemia

米托蒽醌在儿童急性髓系白血病中的群体药代动力学和剂量-反应关系

2026-01-010
OAAI
Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study

Blinatumomab巩固治疗在具有高风险初发复发B细胞前体急性淋巴细胞白血病儿童中的疗效:一项随机多中心III期研究的最终5年随访分析

Leukemia
IF13.4
2025-11-130
PRE
Use of Ommaya Reservoirs in the management of acute leukemias in children and adolescents: Guidelines from the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE) Committee

Ommaya储液囊在儿童和青少年急性白血病管理中的应用:法国儿童和青少年癌症与白血病学会(SFCE)委员会指南

2025-11-010
PRE
Childhood isolated C3d-positive AIHA: favorable prognosis but rare relapse or associated immunodeficiency

儿童孤立性C3d阳性AIHA:预后良好,但复发或相关免疫缺陷罕见

2025-10-240
OAAI
Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert Panel

儿童急性髓系白血病(AML)的诊断与管理:国际专家小组的共识建议

Blood
IF23.1
2025-10-220
PRE
Pediatric erythroblastic sarcoma/pure erythroid leukemia with NFIA-CBFA2T3 translocation: Report of two cases, including a case with TP53 mutation, and review of the literature
2025-10-010
OAAI
Chemo-Immunotherapy Rescue for High-Risk Neuroblastoma Patients With Progressive Disease Before High-Dose Chemotherapy: Real-World Data From the SACHA-France Study

高危神经母细胞瘤患者在接受大剂量化疗前进展性疾病患者的化疗-免疫疗法挽救治疗:来自SACHA-France研究的真实世界数据

2025-10-010
OAAI
The watch-and-wait approach for patients with juvenile myelomonocytic leukemia: results of the French cohort

对于儿童骨髓单核细胞白血病患者采取的观察等待策略:法国队列研究的结果

Blood
IF23.1
2025-09-220
PRE
Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL)

基于甲基化对TAL1阳性T细胞急性淋巴细胞白血病(T-ALL)的重新定义

Leukemia
IF13.4
2025-08-080
PRE
Oncogenomic profiling in infant-toddler T-ALL identifies NKX2 family genes as drivers linked to favorable outcomes

婴幼儿t-all的肿瘤基因组分析将NKX2家族基因确定为与有利结果相关的驱动因素

2025-05-270
OA
Epidemiology, incidence, and outcome of childhood cancers in the Afro-descendant population of the French West Indies and French Guiana: a population-based study

流行病学、发病率和儿童癌症结局在法属西印度群岛和法属圭亚那的非洲裔人口中的研究:一项基于人群的研究

2025-04-011
OAAI
How to Administer Pegaspargase during Induction Treatment of Acute Lymphoblastic Leukemia in Children and Adolescents? Results of the Caall-F01, a Multicentre Randomized Clinical Trial from the French Pediatric Cancer Society (SFCE)

如何在儿童和青少年急性淋巴细胞白血病的诱导治疗期间使用Pegaspargase?Caall-F01研究结果,一项来自法国儿科肿瘤学会(SFCE)的多中心随机临床试验。

BLOOD
IF23.1
2024-11-050
PRE
Developmental interplay between transcriptional alterations and a targetable cytokine signaling dependency in pediatric ETO2::GLIS2 leukemia

小儿ETO2::GLIS2白血病中转录改变与可靶向细胞因子信号传导依赖性之间的发育相互作用

2024-09-200
OAAI